Microglia: a sensor for pathological events in the CNS.
Function and regulation of CREB family transcription factors in the nervous system.
Astrocytes: biology and pathology.
Disruption of the Cbfa2 gene causes necrosis and hemorrhaging in the central nervous system and blocks definitive hematopoiesis.
Allosteric modulators of GPCRs: a novel approach for the treatment of CNS disorders.
Local self-renewal can sustain CNS microglia maintenance and function throughout adult life.
Therapeutic application of histone deacetylase inhibitors for central nervous system disorders.
Suppression of autoimmune inflammation of the central nervous system by interleukin 10 secreted by interleukin 27-stimulated T cells.
The HMG-CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune disease.
Stem cells in the central nervous system.
Microglia as mediators of inflammatory and degenerative diseases.
Neuronal migration, with special reference to developing human brain: a review.
Targeting the endocannabinoid system: to enhance or reduce?
The role of inflammation in CNS injury and disease.
A FAMILIAL DISORDER OF URIC ACID METABOLISM AND CENTRAL NERVOUS SYSTEM FUNCTION.
Glial fibrillary acidic protein: GFAP-thirty-one years (1969-2000).
CNS injury, glial scars, and inflammation: Inhibitory extracellular matrices and regeneration failure.
Age-dependent emergence and progression of a tauopathy in transgenic mice overexpressing the shortest human tau isoform.
An apparently new enterovirus isolated from patients with disease of the central nervous system.
Cholesterol metabolism in the brain.